Almost exactly a year ago Medtronic (NYSE:MDT) CEO Omar Ishrak insisted that value-based healthcare is the salvation, not the damnation, of the medical device industry.
European regulators granted market clearance for Covidien‘s (NYSE:COV) Stellarex drug-eluting balloon for treating peripheral artery disease, the company said today.